The management team has acquired Referencia SAS
The management team has acquired Referencia SAS.
Referencia is the spin-off of Refinancia’s specialty finance unit. With 50 employees, the company offers three main products: Li$to, Fenalcheque and loan guarantees. Li$to's point of sale credits finances an underserved consumer credit market in Colombia. Fenalcheque guarantees post-dated checks to retailers, educational and financial institutions. Loan guarantees are offered to financial institutions on certain types of loans such as education financing. Referencia has an exclusive access to Colombia’s largest merchant network. Private customers benefit from having competitive financing without using up credit card limits while professionals are provided with alternative financing that allows them to increase sales.
Oaklins' team in Colombia acted as financial advisor in the specialty finance spin-off.
Talk to the deal team
Related deals
True Securitizadora has been acquired by Opea
The private shareholders of True Securitizadora have sold the company to Opea Securitizadora. The acquisition is part of Opea’s strategy to expand its portfolio of services and products, and reinforce its operations in securitization.
Learn moreFRP Advisory Group plc has finalized a successful secondary placing
FRP Advisory Group plc has completed a fundraising. The book was oversubscribed and approximately £20.4 million (US$33 million) of shares were sold by certain directors and partners of FRP to new and existing institutional investors at 128 pence per ordinary share.
Learn moreTabula Investment Management has been acquired by Janus Henderson Group plc
Tabula Investment Management has been sold to Janus Henderson Group plc. The deal builds on Janus Henderson’s extremely successful active fixed income ETF proposition in the US, where it is the fourth largest provider of active fixed income ETFs by assets under management. The transaction is expected to complete in the second quarter of 2024, subject to usual closing conditions, including regulatory approvals.
Learn more